Validity of self-reported misuse of prescription opioid analgesics

Substance Use and Misuse

Volumn 45, Issue 10, 2010, Pages 1509-1524

  Smith, Meredith ^a   Rosenblum, Andrew ^b   Parrino, Mark ^c   Fong, Chunki ^b   Colucci, Salvatore ^a  

^a PURDUE PHARMA L P   (United States)

^b NATIONAL DEVELOPMENT AND RESEARCH INSTITUTES   (United States)

^c American Association for the Treatment of Opioid Dependence   (United States)

Author keywords

Dilaudid ; Opioid analgesic abuse; OxyContin ; Self reported drug misuse; Validity

Indexed keywords

NARCOTIC ANALGESIC AGENT; PRESCRIPTION DRUG;

ADDICTION; ADOLESCENT; ADULT; AGED; ARTICLE; CROSS-SECTIONAL STUDY; FEMALE; HUMAN; MALE; MIDDLE AGED; QUESTIONNAIRE; SELF DISCLOSURE; STANDARD; UNITED STATES; VALIDATION STUDY;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ANALGESICS, OPIOID; CROSS-SECTIONAL STUDIES; FEMALE; HUMANS; MALE; MIDDLE AGED; PRESCRIPTION DRUGS; QUESTIONNAIRES; SELF DISCLOSURE; SUBSTANCE-RELATED DISORDERS; UNITED STATES; YOUNG ADULT;

EID: 77954230425     PISSN: 10826084     EISSN: 15322491     Source Type: Journal    
DOI: 10.3109/10826081003682107     Document Type: Article

References (56)

1. Aiken, L. S., Lo Sciuto, L. A. (1985). Ex-addict versus nonaddict counselors' knowledge of clients' drug use. International Journal of Addiction, 20:417-433.
2. Amera-Chem Inc. (2005). Drug identification bible. Grand Junction, CO: Amera-Chem Inc.
3. Bailey, J. E., Barton, P. L., Lezotte, D., Lowenstein, S. R., Dart, R. C. (2006). The effect of FDA approval of a generic competitor to OxyContin® (oxycodone HCl controlled-release) tablets on the abuse of oxycodone. Drug and Alcohol Dependence, 84:182-187.
4. Banta, M. (2005, August 1). Trading for a high: an inside look at a pharming party the newest venue for teenage prescription drug abuse. Time, 166:35.
5. Brookoff, D. (1993). Abuse potential of various opioid medications. Journal of General Internal Medicine, 8:688-690.
6. Calhoun, P., Bosworth, H., Hertzberg, M., Sampson, W., Feldman, M. E., Kirby, A., et al. (2006). Drug use and validity of substance use self-reports in veterans seeking help for Posttraumatic Stress Disorder. American Journal on Addictions 15:92-101.
7. Carise, D., Dugosh, K. L., McLellan, A. T, Camilleri, A., Woody, G. E., Lynch, K. G. (2007). Prescription OxyContin abuse among patients entering addiction treatment. American Journal of Psychiatry, 164:1750-1756.
8. Cicero, T. J., Inciardi, J. A., Munoz, A. (2005). Trends in the abuse of OxyContin and other opioid analgesics in the United States: 2002-2004. Journal of Pain, 6:662-672.
9. Cisin, I. H., Parry, H. L. (1979). Sensitivity of survey techniques in measuring illicit drug use. In: J. D. Rittenhouse (Ed.), Developmental papers: attempts to improve the measurement of heroin use in the National Survey (pp. 3-46). Washington, DC: National Institute on Drug Abuse.
10. Cohen, J. (1960). A coefficient of agreement for nominal scales. Educational and Psychological Measurement, 20:37-46.
11. Cólon, H. M., Robles, R. R., Sahai, H. (2001). The validity of drug use responses in a household survey in Puerto-Rico: comparison of survey responses of cocaine and heroin use with hair tests. International Journal of Epidemiology, 30:1042-1049.
12. Compton, W. M., Volkow, N. D. (2006). Major increases in opioid analgesic abuse in the United States: concerns and strategies. Drug and Alcohol Dependence 81:103-107.
13. Cordingley, J., Wilkinson, D. A., Martin, G. W. (1990). Corroborating multiple drug users' posttreatment self-reports by collaterals. Behavioral Assessment, 12:253-264.
14. Corliss, R. (2001, March 19) Who's feeling no pain? Time, 157(11):69.
15. Dasgupta, N., Kramer, E. D., Zalman, M., Carino, S. Jr, Smith, M. Y., Haddox, J. D., et al. (2006). Association between non-medical and prescriptive usage of opioids. Drug and Alcohol Dependence, 82:135-142.
16. Del Boca, F. K., Noll, J. A. (2000). Truth or consequences: the validity of self-report data in health services research on addictions. Addiction, 95:S347-S360.
17. Fendrich, M., Mackesy-Amiti, M. E., Johnson, T. P., Hubbell, A., Wislar, J. S. (2005). Tobacco-reporting validity in an epidemiological drug-use survey. Addictive Behaviors 30:175-181.
18. Fleiss, J. L. (1981). Statistical methods for rates and proportions (2nd ed., pp. 38-46). New York: Wiley.
19. Food and Drug Administration. (2004). Drugs at FDA. Retrieved September 17, 2004, from http://www/accessdata/fda/gpvscriptscder/drugsatfda/index.cfm? CFID=3223871&CFTOKEN=35800008
20. Glenberg, A. M., Langston, W. E. (1992). Comprehension of illustrated text: pictures help to build mental models. Journal of Memory and Language, 31:129-151.
21. Hall, A. J., Logan, J. E., Toblin, R. L., Kaplan, J. A., Kraner, J. C., Bixler, D., et al. (2008). Patterns of abuse among unintentional pharmaceutical overdose fatalities. JAMA: The Journal of the American Medical Association, 300:2613-2620.
22. Harrison, L., Hughes, A. (Eds.). (1997). The validity of self-reported drug use: improving the accuracy of survey estimates. (NIH Publication No. 97-4147. U.S. Department of Health and Human Services, Washington, DC.) Rockville, MD: National Institute on Drug Abuse.
23. Harrison, L. D., Martin, S. S., Enev, T., Harrington, D. (2007). Comparing drug testing and self-report of drug use among youths and young adults in the general population. (DHHS Publication No. SMA-07-4249, Methodology Series M-7.) Rockville, MD: Substance Abuse and Mental Health Services Administration, Office of Applied Studies.
24. Hill, P. C., Dill, C. A., Davenport, E. C. (1988). A reexamination of the bogus pipeline. Educational and Psychological Measurement. 48:587-601.
25. Hser, Y.-I. (1997). Self-report drug use: results of selected empirical investigations of validity. In: L. Harrison, A. Hughes, (Eds.), (The validity of self-reported drug use: improving the accuracy of survey estimates. (NIH Publication No. 97-4147. U.S. Department of Health and Human Services, Washington, DC, pp. 320-343). Rockville, MD: National Institute on Drug Abuse.
26. Hubbard, R. L., Eckerman, W. C., Rachal, J. V., Williams, J. R., (1977). Factors affecting the validity of self-reports of drug use: an overview. Proceedings of the American Statistical Association, Social Statistics Section, Chicago, IL.
27. Inciardi, J. A., Surratt, H. L., Kurtz, S. P., Cicero, T. J. (2007). Mechanisms of prescription drug diversion among drug-involved club-and street-based populations. Pain Medicine, 8: 171-183.
28. Johnston, L. D., O'Malley, P. M. (1997). The recanting of earlier reported drug use by young adults. In: L. Harrison, A. Hughes, (Eds.), (The validity of self-reported drug use: improving the accuracy of survey estimates. (NIH Publication No. 97-4147. U.S. Department of Health and Human Services, Washington, DC, pp. 59-80.) Rockville, MD: National Institute on Drug Abuse.
29. Johnston, L. D., O'Malley, P. M., Bachman, J. G., Schulenberg, J. E. (2007). Monitoring the future national survey results on drug use, 1975-2006. Volume I: secondary school students. (NIH Publication No. 07-6205. U.S. Department of Health and Human Services, Washington, DC.) Bethesda, MD: National Institute on Drug Abuse.
30. Landis, J. R., Koch, G. G. (1977). The measurement of observer agreement for categorical data. Biometrics, 33:159-174.
31. Lennox, R., Dennis, J. L., Ives, M., White, M. K. (2006). The construct and predictive validity of different approaches to combining urine and self-reported drug use measures among older adolescents after substance abuse treatment. American Journal on Addictions, 15:92-101.
32. Levy, M. S. (2007). An exploratory study of OxyContin use among individuals with substance use disorders. Journal of Psychoactive Drugs, 39:271-276.
33. Magura, S., Goldsmith, D., Casriel, C, Goldstein, P. J., Lipton, D. S. (1987). The validity of methadone clients' self-reported drug use. The International Journal of Addictions, 22:727-749.
34. Magura, S., Kang, S. Y. (1996). Validity of self-reported drug use in high risk populations: a meta-analytical review. Substance Use and Misuse, 31:1131-1153.
35. Maisto, S. A., McKay, J. R., Connors, G. J. (1990). Self-report issues in substance abuse: state of the art and future directions. Behavior Assessment, 12:117-134.
36. McCabe, S. E. (2004). Comparison of web and mail surveys in collecting illicit drug use data: a randomized experiment. Journal of Drug Education, 34:61-72.
37. McCabe, S. E., Cranford, J. A., Boyd, C. J., Teter, C. J. (2007). Motives, diversion and routes of administration associated with nonmedical use of prescription opioids. Addictive Behaviors, 32:562-575.
38. McBride, D. C, McCoy, C. B., Rivers, J. E., Lincoln, C. A. (1980). Dilaudid® use: trends and characteristics of users. Chemical Dependencies, 4:85-100.
39. Meier, B. (2003). Pain killer: a "wonder" drug's trial of addiction and death. Emmaus, PA: Rodale.
40. Page, W. F., Davies, J. E., Ladner, R. A., Alfassa, J. (1977). Urinalysis screened vs. verbally reported drug use: the identification of discrepant groups. The International Journal of Addictions, 12:439-450.
41. Phillips, R. J. (1986). Computer graphics as memory aid and a thinking aid. Journal of Computer Assisted Learning, 2:37-44.
42. Podsakoff, P. M., MacKenzie, S. B., Lee, J.-Y. (2003). Common method biases in behavioral research: a critical review of the literature and recommended remedies. Journal of Applied Psychology, 88:879-903.
43. Roche, T. (2001, January 8). The potent perils of a miracle drug. Time, 157:47.
44. Rosenblum, A., Parrino, M., Schnoll, S., Fong, C, Maxwell, C, Cleeland, C. M., et al. (2007). Prescription opioid abuse among enrollees into methadone maintenance treatment. Drug and Alcohol Dependence, 90:64-71.
45. Sajan, A., Corneil, T., Grzybowski, S. (1998). The street value of prescription drugs. CMAJ: Canadian Medical Association Journal, 159:139-142.
46. Sees, K. L., DiMarino, M. E., Ruediger, N. K., Sweeney, C. T., Shiffman, S. (2005). Non-medical use of Oxycontin tablets in the United States. Journal of Pain & Palliative Care Pharmacotherapy, 19:13-23.
47. Smith, M. Y, Haddox, J. D., DiMarino, M. E. (2007). Correlates of nonmedical use of hydromorphone and hydrocodone: results from a National Household Survey. Journal of Pain & Palliative Care Pharmacotherapy, 21:5-17.
48. Sobell, L. C, Sobell, M. B. (1980). Convergent validity: an approach to increasing confidence in treatment outcome conclusions with alcohol and drug abusers. In: L. C. Sobell, M. B. Sobell & E. Wards, (Eds.), (Evaluating alcohol and drug abuse treatment effectiveness: recent advances (pp. 177-183). New York: Pergamon Press.
49. Solbergsdottir, E., Bjornsson, G., Gudmundsson, L. S., Tyrfingsson, T., Kristinsson, J. (2004). Validity of self-reports and drug use among young people seeking treatment for substance abuse or dependence. Journal of Addictive Diseases, 23:29-38.
50. Statistical Analysis Software (SAS). (1999). Version 8.0. Cary, NC: SAS Institute, Inc.
51. Substance Abuse and Mental Health Administration, Office of Applied Studies. (2008). Results from the 2007 National Survey on Drug Use and Health: National findings. (NSDUH Series H-34, DHHS Publication No. SMA 08-4343.) Rockville, MD: Author.
52. Teleform (2001). Version 8.2. Sunnyvale, CA: Verity, Inc.
53. Tough, P. (2001, July 29). The alchemy of OxyContin. NYTimes, 32-49.
54. Wish, E. D., Hoffman, J., Nemes, S. (1997). The validity of self-reports of drug use at treatment admission and at followup: comparisons with urinalysis and hair assays. In: L. Harrison, A. Hughes, (Eds.), (The validity of self-reported drug use: improving the accuracy of survey estimates. (NIH Publication No. 97-4147. U.S. Department of Health and Human Services, Washington, DC, pp. 200 - 226). Rockville, MD: National Institute on Drug Abuse.
55. Woolf, C.H., Hashmi, M. (2004). Use and abuse of opioid analgesics: potential methods to prevent and deter non-medical consumption of prescription opioids. Current Opinion in Investigational Drugs, 5:61-66.
56. Zacny, J., Bigelow, G., Compton, P., Foley, K., Iguchi, M., Sannerud, C. (2006). College on problems of drug dependence taskforce on prescription opioid non-medical use and abuse: position statement. Drug and Alcohol Dependence, 69:215-232.